%0 Journal Article
%T Calculated Tumor Volume Is an Independent Predictor of Biochemical Recurrence in Patients Who Underwent Retropubic Radical Prostatectomy
%A Nobumichi Tanaka
%A Kiyohide Fujimoto
%A Akihide Hirayama
%A Yasushi Nakai
%A Yoshitomo Chihara
%A Satoshi Anai
%A Atsushi Tomioka
%A Keiji Shimada
%A Noboru Konishi
%A Yoshihiko Hirao
%J Advances in Urology
%D 2012
%I Hindawi Publishing Corporation
%R 10.1155/2012/204215
%X Purpose. The purpose of this study is to investigate whether the clinicopathological biopsy findings can predict the oncological outcome in patients who undergo radical prostatectomy. Materials and Methods. Between January 1997 and March 2006, 255 patients with clinically localized adenocarcinoma of the prostate (clinical T1-3N0M0) who had undergone retropubic radical prostatectomy were enrolled in this study. None of the patients received neoadjuvant or adjuvant therapy. Clinicopathological parameters were assessed to determine a predictive parameter of biochemical recurrence. Results. Of the total 255 patients, 77 showed biochemical recurrence during the follow-up period. The estimated 5-year overall survival, 5-year cause-specific survival, and 5-year biochemical recurrence-free survival rates were 97.7%, 99.5%, and 67.3%, respectively. Multivariate analysis using the Cox proportional hazards model showed that calculated cancer volume was an independent predictor among the preoperative clinicopathological parameters ( ). SVI and PSM were independent predictors among the postoperative parameters (SVI; , PSM; ). Among the significant preoperative and postoperative parameters, calculated cancer volume remained an independent predictive parameter in multivariate analysis ( ). Conclusions. Tumor volume, as calculated by preoperative parameters, is an independent predictor of biochemical recurrence in patients who had undergone radical prostatectomy. 1. Introduction Radical prostatectomy has been the gold standard of definitive therapy for patients with localized prostate cancer for years [1]. Now, not only laparoscopic radical prostatectomy, but recently also robotic radical prostatectomy has remained popular over the years all across the world [2, 3]. Prostate cancer patients have been able to choose their primary treatment modality among several treatment options since the technical development of radiation therapy such as 3-dimensional conformal radiation therapy (3-DCRT), intensity modulated radiation therapy (IMRT), low-dose-rate brachytherapy (LDR-brachytherapy), and high-dose-rate brachytherapy (HDR-brachytherapy) [4]. If it is possible to predict the oncological outcome based on the clinicopathological findings at diagnosis, it will be possible to choose the most suitable treatment option in patients who receive definitive therapy. The purpose of this study is to investigate whether the clinicopathological biopsy findings can predict the oncological outcome in patients who are undergoing radical prostatectomy. 2. Material and Methods Between
%U http://www.hindawi.com/journals/au/2012/204215/